Aamal Medical, a leading provider of healthcare solutions in the Middle East, and Gleamer, a renowned French MedTech company specializing in artificial intelligence (AI) applications for radiology, are delighted to announce a strategic partnership. This collaboration aims to extend Gleamer’s global presence, particularly in the Middle East, and reinforce Qatar's commitment to investing in innovative healthcare technologies.

The partnership marks a significant step for Aamal Medical in enhancing its portfolio with cutting-edge technology. Aamal Medical has over 50 years of experience providing comprehensive healthcare solutions and services. Mr. Gokhan Ozkan, General Manager of Aamal Medical, commented: “We are excited to announce our collaboration with Gleamer, as we are dedicated to supporting the Qatar healthcare sector with cutting-edge medical innovations and technology through collaborations with global healthcare leaders. Gleamer has great experience in radiology AI, especially in the pediatric field, which we feel is a great addition to our offerings to Qatar healthcare.”

Gleamer, known for its AI-powered tools BoneView & ChestView, which aid in X-ray imaging, is set to expand its global footprint through this alliance. Christian Allouche, CEO of Gleamer, commented on the partnership's significance: “We are confident that our AI solutions will significantly enhance radiological diagnostics in Qatar, reducing diagnostic errors and improving patient outcomes.”

This partnership will bring a new era of radiological diagnostics to the Middle East, offering healthcare providers in the region access to world-class AI technology. The integration of Gleamer's AI solutions in Aamal Medical's offerings is a testament to the global recognition of Gleamer's technology. It highlights the potential of AI in transforming healthcare practices worldwide.